Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.0.1
Consolidated Balance Sheets - USD ($)
Nov. 30, 2021
Nov. 30, 2020
Current Assets    
Cash and cash equivalents $ 8,263,088 $ 10,361,125
Marketable securities 75,412 88,476
Accounts receivable (net of allowance for doubtful accounts of $3,078,439 and $2,781,668, respectively) 5,253,173 6,322,960
Prepaid expenses 558,413 611,627
Inventory, current portion 921,213 927,318
Other current assets 711,208 244,696
Total current assets 15,782,507 18,556,202
Property and Equipment-net 3,230,204 1,640,774
Noncurrent Assets    
Duke license agreement, net 14,651,802  
Intangible assets, net 1,559,693 1,181,588
Inventory, net of current portion 9,695,363 11,064,034
Goodwill 1,941,411 1,941,411
Deferred tax assets 12,010,133 10,363,967
Operating lease right-of-use asset 916,493 299,089
Deposits and other assets, net 566,470 495,029
Total noncurrent assets 41,649,365 26,003,118
Total assets 60,662,076 46,200,094
Current Liabilities    
Accounts payable 1,489,774 957,390
Accrued expenses 3,057,386 2,898,211
Current portion of note payable 1,898,065 3,100,000
Current portion of operating lease liability 312,067 275,570
Current portion of Duke license agreement liability 4,957,591  
Deferred revenue 9,358,696 9,183,450
Total current liabilities 21,073,579 16,414,621
Other Liabilities    
Deferred revenue, net of current portion 31,274,214 27,200,910
Contingent consideration 727,371 1,509,852
Note payable, net of current portion and debt issuance costs   2,841,214
Operating lease long-term liability 610,989 23,632
Long-term liability - revenue sharing agreements 875,000 875,000
Total other liabilities 35,404,183 32,450,608
Total liabilities 56,477,762 48,865,229
Commitments and contingencies (Note 12) 0 0
Stockholders' Equity (Deficit)    
Preferred stock 0 0
Common stock ($.01 par value, 20,000,000 authorized; 14,665,772 issued and 8,557,326 outstanding as of November 30, 2021 and 13,633,638 issued and 7,545,613 outstanding as of November 30, 2020) 146,658 136,336
Additional paid-in capital 41,586,583 36,581,600
Treasury stock, at cost (20,812,734) (20,563,357)
Accumulated deficit (16,736,193) (18,819,714)
Total stockholders' equity (deficit) 4,184,314 (2,665,135)
Total liabilities and stockholders' equity (deficit) 60,662,076 46,200,094
Series A Junior Participating Preferred Stock [Member]    
Stockholders' Equity (Deficit)    
Preferred stock 0 0
Tianhe Stem Cell Biotechnologies Inc [Member]    
Noncurrent Assets    
Investment 308,000 308,000
Patent Option Agreement [Member]    
Noncurrent Assets    
Investment   $ 350,000
Duke University [Member]    
Other Liabilities    
Duke license agreement liability $ 1,916,609